Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2024-03-06 00:00:00 ET · period of report 2024-03-04 · accession 0001062993-24-005773 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-06 | 2024-03-04 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +31.3K | 154.3K | +25% | $0 |
| D | 2024-03-06 | 2024-03-04 | ADPT | NEUPERT PETER M | Dir | A - Grant | $0.00 | +48.0K | 48.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-04 | A | A | 31,328 | $0.00 | 154,296 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2024-03-04 | A | A | 48,044 | $0.00 | 48,044 | D | $3.99 · — to 2034-03-04 | 48,044 Common Stock | (F1) The option will vest in equal monthly installments over one year from March 4, 2024, subject to continued service as a director through such vesting dates. |